Th22 Cell Is a Gradually Proved Potential Biomarker for Acute Coronary Syndrome
Saved in:
Main Authors: | Ying Huang, Tao Xu, Jun Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2014/813926 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Circulating Th17, Th22, and Th1 Cells Are Elevated in the Guillain-Barré Syndrome and Downregulated by IVIg Treatments
by: Shujuan Li, et al.
Published: (2014-01-01) -
Biomarkers of residual risk and all-cause mortality after acute coronary syndrome.
by: Anna Toso, et al.
Published: (2025-03-01) -
Levels of Pathogenic Th17 and Th22 Cells in Patients with Rheumatoid Arthritis
by: Marlen Vitales-Noyola, et al.
Published: (2022-01-01) -
Ultrasonic Assessment of Females with Carpal Tunnel Syndrome Proved by Nerve Conduction Study
by: Ihsan M. Ajeena, et al.
Published: (2013-01-01) -
Acute Coronary Syndrome Mimicking Takotsubo Cardiomyopathy or Takotsubo Cardiomyopathy Mimicking Acute Coronary Syndrome?
by: Martin Chaumont, et al.
Published: (2020-01-01)